Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on multi component reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Novel one-step acid-catalyzed method for quinazolinones using isatoic anhydride. High purity, scalable, cost-effective pharmaceutical intermediates manufacturing.
Patent CN116640146B enables efficient synthesis of trifluoromethyl chromonoquinoline intermediates through palladium-catalyzed multicomponent reactions with simplified processing and scalable manufacturing advantages.
Novel palladium-catalyzed method enables efficient synthesis of trifluoromethyl chromone quinoline intermediates with simplified purification and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN112279801B enables cost-effective production of high-purity 3-methylsulfonyl nitrogen heterocycles through one-pot synthesis with broad substrate scope.
Palladium-catalyzed synthesis enables high-purity pyrrolofuran intermediates with cost reduction in pharmaceutical manufacturing.
Discover a cost-effective, high-yield synthesis of trifluoromethyl-substituted chromone quinoline via palladium-catalyzed one-pot method. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve high-cost synthesis challenges of trifluoromethyl chromonoquinolines. Our CDMO expertise delivers scalable, high-yield routes with 99%+ purity for drug development.
Reduce synthesis steps from 5-7 to 1 with high-yield palladium-catalyzed route. Eliminate anhydrous equipment costs and ensure 99%+ purity for pharma intermediates.
Solve CO gas safety risks and low substrate tolerance in biheterocycle synthesis. Our CDMO expertise scales this metal-catalyzed method to 100MT/yr with >99% purity.
Solve supply chain risks with this Pd-catalyzed one-pot synthesis. 3-iodochromone as cheap starting material, 110-130°C reaction, high yield. Ideal for API intermediates.
Discover efficient, scalable synthesis of 3-trifluoromethyl 1,2,4-triazole compounds with >90% yields. Ideal for API manufacturing and drug development.
Solve low-yield issues in trifluoromethyl heterocycle synthesis. Our CDMO expertise scales this palladium-catalyzed method for high-purity API intermediates with 99%+ purity.
Solve supply chain risks with CO-free synthesis of trifluoromethylated biheterocycles. NINGBO INNO PHARMCHEM delivers 99%+ purity at 100kgs/yr scale for drug development.
Discover a cost-effective, high-yield synthesis of trifluoromethyl chromone quinoline via palladium-catalyzed one-pot method. Ideal for pharmaceutical intermediates with broad substrate tolerance and scalable production.
Solve supply chain risks with metal-free carbonylation. Low-cost, scalable synthesis of trifluoromethylated biheterocycles for pharma R&D and production.
Discover a scalable, air-tolerant 3-cyanindole synthesis method with 88% yield. Reduce costs and supply chain risks for cardiovascular drug intermediates.
Avoid toxic reagents and multi-step purification with this 60-75% yield 3-cyanoindole synthesis. Reduce production costs by 40% for drug development.
Discover a cost-effective, air-tolerant synthesis of 3-cyanindole intermediates with high yields and simplified process, reducing supply chain risks for pharma R&D and procurement.
Eliminate CO gas risks and high costs in biheterocyclic synthesis. Our CDMO expertise scales this CO-free palladium method for high-purity pharmaceutical intermediates with >99% purity.